Md Ali Mujtaba
Impact in
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 23
- Drug Solubulity and Delivery Systems 15
- Advancements in Transdermal Drug Delivery 11
-
- RNA Interference and Gene Delivery 5
- Co-authors
- Kanchan Kohli (11 shared papers)Md Habban Akhter (6 shared papers)Mushir Ali (3 shared papers)Saima Amin (3 shared papers)Md. Rizwanullah (2 shared papers)Javed Ahmad (2 shared papers)Kriti Soni (3 shared papers)Ameeduzzafar Zafar (13 shared papers)
- Journals
- International Journal of Biological Macromolecules (4 papers)ACS Omega (3 papers)RSC Advances (3 papers)Current Pharmaceutical Biotechnology (3 papers)Biomedical Materials (2 papers)
- Partner nations
- Saudi ArabiaIndiaMalaysia
In The Last Decade
Md Ali Mujtaba
56 papers receiving 790 citations
Peers
Comparison fields: 5 of 115
- Pharmaceutical Science 311
- Biomaterials 169
- Molecular Medicine 59
- Pharmacology 60
- Pharmacology 97
Countries citing papers authored by Md Ali Mujtaba
This map shows the geographic impact of Md Ali Mujtaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Md Ali Mujtaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Md Ali Mujtaba more than expected).
Fields of papers citing papers by Md Ali Mujtaba
This network shows the impact of papers produced by Md Ali Mujtaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Md Ali Mujtaba. The network helps show where Md Ali Mujtaba may publish in the future.
Co-authors
The 25 scholars most cited alongside Md Ali Mujtaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 103 | |
| 2 | 2017 | 87 | |
| 3 | 2019 | 51 | |
| 4 | 2020 | 50 | |
| 5 | 2013 | 48 | |
| 6 | 2021 | 39 | |
| 7 | 2021 | 34 | |
| 8 | 2014 | 31 | |
| 9 | 2017 | 29 | |
| 10 | 2016 | 28 | |
| 11 | 2021 | 28 | |
| 12 | 2020 | 28 | |
| 13 | 2020 | 25 | |
| 14 | 2019 | 20 | |
| 15 | 2020 | 15 | |
| 16 | 2022 | 15 | |
| 17 | 2011 | 14 | |
| 18 | 2021 | 14 | |
| 19 | 2022 | 10 | |
| 20 | 2024 | 9 |
About Md Ali Mujtaba
Md Ali Mujtaba is a scholar working on Pharmaceutical Science, Molecular Biology, Pharmacology, Biomaterials and Pharmacology, having authored 65 papers that have together received 806 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (23 papers), Drug Solubulity and Delivery Systems (15 papers), Advancements in Transdermal Drug Delivery (11 papers), Nanoparticle-Based Drug Delivery (10 papers), Analytical Methods in Pharmaceuticals (6 papers), RNA Interference and Gene Delivery (5 papers), Nanoplatforms for cancer theranostics (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). The work is most often cited by research in Pharmaceutical Science (311 citations), Biomaterials (169 citations), Molecular Medicine (59 citations), Pharmacology (60 citations) and Pharmacology (97 citations). Md Ali Mujtaba has collaborated with scholars based in Saudi Arabia, India and Malaysia. Frequent co-authors include Kanchan Kohli, Md Habban Akhter, Mushir Ali, Saima Amin, Md. Rizwanullah, Javed Ahmad, Kriti Soni, Ameeduzzafar Zafar, Mohamed Jawed Ahsan and Javed Ali. Their work appears in journals such as International Journal of Biological Macromolecules, ACS Omega, RSC Advances, Current Pharmaceutical Biotechnology and Biomedical Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.